Epigenomics AG Sustainability Reports
Epigenomics AG acts as a holding company managing its assets and investments in companies focused on blood-based cancer detection. The company previously specialized in developing molecular diagnostic products utilizing DNA methylation technologies.
Sector: Professional & technical services
Country: Germany
Exchange: Börse Frankfurt
LEI: 549300X1C4U862NDLN97
FIGI: BBG001S95635
29 reports from 2007 to 2025